EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Percutaneous microwave ablation combined with simultaneous transarterial chemoembolization for hepatocellular carcinoma with macrovascular invasion or extrahepatic metastases

Mengfei Wu, Shanshan Gao, Huadan Song, Zihan Zhang, Zhiyuan Zheng, Zhiping Yan, Xiaolin Wang, Jianhua Wang, Lingxiao Liu

Journal of Interventional Medicine · 2019

DOI: 10.1016/j.jimed.2019.07.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Interventional Medicine, 2019. Verfasst von Mengfei Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To evaluate the safety and efficacy of percutaneous microwave ablation (MWA) combined with simultaneous transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC) patients with microvascular invasion (MVI) or extrahepatic metastases (EHM). METHODS: Between August 2012 and April 2017, 101 patients with MVI/EHM of HCC underwent percutaneous MWA combined with simultaneous TACE at our center. The clinical data were collected and analyzed for survival and prognostic factors. RESULTS: The mean follow-up time was 23.6 ± 14.7 months. One patient had grade 3 complications, and the median overall survival was 12.0 months (95% confidence interval 9.7-14.3). Multivariate analysis showed that Child-Pugh class, serum alpha-fetoprotein level, and Eastern Cooperative Oncology Group performance status were independent factors of survival. CONCLUSION: Our results suggest that percutaneous MWA combined with simultaneous TACE is a safe and effective treatment for HCC with MVI/EHM.

Schlagwörter

Stichwörter der Autor:innen

Combination therapyHepatocellular carcinomaMicrowave ablationSurvival

Autor:innen und Institutionen

  • Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
  • Shanghai Institute of Medical Imaging, Shanghai, 200032, China.

Zitieren

APA

Wu, M., Gao, S., Song, H., Zhang, Z., Zheng, Z., Yan, Z., Wang, X., Wang, J., & Liu, L. (2019). Percutaneous microwave ablation combined with simultaneous transarterial chemoembolization for hepatocellular carcinoma with macrovascular invasion or extrahepatic metastases. Journal of Interventional Medicine. https://doi.org/10.1016/j.jimed.2019.07.003

Vancouver

Wu M, Gao S, Song H, Zhang Z, Zheng Z, Yan Z, et al. Percutaneous microwave ablation combined with simultaneous transarterial chemoembolization for hepatocellular carcinoma with macrovascular invasion or extrahepatic metastases. Journal of Interventional Medicine. 2019. doi:10.1016/j.jimed.2019.07.003

BibTeX
@article{Wu2019,
  author = {Wu, Mengfei and Gao, Shanshan and Song, Huadan and Zhang, Zihan and Zheng, Zhiyuan and Yan, Zhiping and Wang, Xiaolin and Wang, Jianhua and Liu, Lingxiao},
  title = {Percutaneous microwave ablation combined with simultaneous transarterial chemoembolization for hepatocellular carcinoma with macrovascular invasion or extrahepatic metastases},
  journal = {Journal of Interventional Medicine},
  year = {2019},
  doi = {10.1016/j.jimed.2019.07.003}
}
Kostenlos starten →